ComputChem Awarded $1,373,997in SBIR Phase II Funding from the National Institutes of Health

By |2022-07-20T17:36:26+00:00July 20th, 2022|Latest News|

SBIR award will enable ComputChem to create software for better drug design and development November 19, 2021, Baltimore, MD – ComputChem, a technology company building next-generation platform solutions for in silico covalent drug design and lead optimization, today announced it has been awarded a $1,373,997 Small Business Innovation Research (SBIR) Phase II grant from the